Back to the main directory
EarningsReview / Equity
- Getinge (Buy, TP: SEK320.00) - An excellent quarter by DnB Markets
- Medistim (Sell, TP: NOK214.00) - Challenging comparables by DnB Markets
- Demant (Hold, TP: DKK320.00) - Recovery continues by DnB Markets
- SSAB (Buy, TP: SEK58.00) - A flying start to 2021 by DnB Markets
- Lundin Mining (Buy, TP: SEK120.00) - Favourable scenario ahead by DnB Markets
- Pareto Bank (Buy, TP: NOK57.00) - Superior NII on high activity by DnB Markets
- Seafood - Fat Trout Weekly by DnB Markets
- More transactions, and Q1 results by DnB Markets
- It''s the NAV not just the discount by BNP Paribas Exane
- Pre-announces Q1 license beat. What about RISE? by BNP Paribas Exane
- Well, well, well... by BNP Paribas Exane
- Beautiful growth but margins lack muscle (and 15 Qs) by BNP Paribas Exane
- Q1: A flying start to 2021 by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Carbon Markets: April 2021 by BNP Paribas Exane
- Impressive growth for NOW by BNP Paribas Exane
- Upping ambition by BNP Paribas Exane
- Underlying market growth accelerates by BNP Paribas Exane
- Q1 earnings preview - we expect Advertising upside by BNP Paribas Exane
- Recovery underway. MandA contributions continue by BNP Paribas Exane
- Ready, Willing and Nagle by BNP Paribas Exane
- Back to normalization as lack of secular growth looms by BNP Paribas Exane
- Q121 sales and 15 questions for management by BNP Paribas Exane
- Still waiting for greenfield demand to pick-up by BNP Paribas Exane
- Q1''21: in-line, but long-term worries remain by BNP Paribas Exane